| Literature DB >> 29910281 |
Floris Wardenaar1, Remko van den Dool2, Ingrid Ceelen3, Renger Witkamp4, Marco Mensink5.
Abstract
The purpose of the present study was to determine the prevalence of dietary supplements (DS's) and sport nutrition product (SNPs) among the general population, to identify differences for gender, age, and exercise frequency, and to determine the main reasons for use. The study was designed as a web-based questionnaire in a representative sample (n = 1544) of the Dutch population. Sixty-two percent (n = 957) of the respondents reported having used DS's, SNPs, or both in the last twelve months. Women and older people reported the highest DS use. The highest use of SNPs was reported by regular exercising men and younger people with improving sporting performance as their main objective. Most frequently reported DS's were multivitamins (28%) and vitamin C (19%)-for SNPs, energy drinks (22%) and isotonic drinks (19%). Health considerations were the most important motivation (DS's 90% and SNPs 52%), but also performance was substantially reported (DS's 14% and SNPs 35%). A substantial group of sedentary respondents also reported the use of SNPs. This study confirms that DS's, SNPs, or both are widely used among the general population. Both health as performance are important reasons for use. It can be questioned whether the use of SNPs fits all respondents' physical activity needs.Entities:
Keywords: exercise; health; nutritional supplements; performance; sports dietetics
Year: 2016 PMID: 29910281 PMCID: PMC5968913 DOI: 10.3390/sports4020033
Source DB: PubMed Journal: Sports (Basel) ISSN: 2075-4663
Prevalence of use of dietary supplements and sports nutrition products.
| Gender | Age (Years) | Sporting Frequency per Year | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Men | Women | 15–20 | 21–35 | 36–50 | 51–65 | 66–80 | 0 | 1–11 | 12–59 | 60–119 | >120 | |
| ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ||
| A | B | C | D | E | F | G | H | I | J | K | L | ||
| Multivitamins/minerals | 28 (26–30) | 23 (20–26) | 32 (29–35) a | 26 (18–34) | 32 (27–37) f,g | 29 (25–31) | 25 (21–29) | 23 (18–28) | 22 (18–26) | 24 (17–31) | 27 (23–31) | 34 (28–40) h,i,j | 34 (28–40) h,i,j |
| Vitamin C | 19 (17–21) | 17 (14–20) | 21 (18–24) | 20 (13–27) | 23 (19–27) g | 19 (15–23) | 19 (15–23) | 13 (9–17) | 15 (11–19) | 17 (11–23) | 20 (16–24) | 22 (17–27) h | 22 (17–27) h |
| Vitamin D | 16 (14–18) | 12 (10–14) | 20 (17–23) a | 13 (7–19) | 17 (13–21) | 12 (9–15) | 16 (12–18) | 21 (16–26) e | 14 (10–18) | 16 (10–22) | 15 (12–18) | 17 (13–21) | 18 (13–23) |
| Calcium | 8 (7–9) | 5 (3–7) | 11 (9–13) a | 7 (2–12) | 6 (3–9) | 5 (3–7) | 11 (8–14) d,e | 14 (10–18) c,d,e | 7 (5–9) | 7 (3–11) | 6 (4–8) | 9 (5–13) | 13 (9–17) h,j |
| Magnesium | 7 (6–8) | 3 (2–4) | 10 (8–12) a | 10 (4–16) d,e | 5 (3–7) | 4 (2–6) | 9 (6–12) d,e | 9 (5–13) e | 7 (5–9) | 5 (1–9) | 5 (3–7) | 6 (3–9) | 11 (7–15) h,j,k |
| Essential fatty acids/fish oil | 5 (4–6) | 3 (2–4) | 6 (4–8) a | 6 (2–10) | 4 (2–6) | 5 (3–7) | 6 (4–8) | 3 (1–5) | 3 (1–5) | 4 (1–7) | 6 (4–8) | 6 (3–9) | 4 (1–7) |
| Iron | 5 (4–6) | 4 (3–5) | 7 (5–9) a | 8 (3–13) | 7 (4–10) | 5 (3–7) | 4 (2–6) | 5 (2–8) | 4 (2–6) | 6 (2–10) | 5 (3–7) | 7 (4–10) | 8 (5–11) h |
| Caffeine | 5 (4–6) | 6 (4–8) | 5 (4–6) | 16 (9–23) d,e,f,g | 8 (5–11) e,f,g | 3 (1–5) | 3 (1–5) | 2 (0–4) | 3 (1–5) | 3 (0–6) | 6 (4–8) h | 6 (3–9) h | 8 (5–11) h |
| Probiotics | 7 (6–8) | 4 (3–5) | 9 (7–11) a | 7 (2–12) | 7 (4–10) | 7 (5–9) | 7 (5–9) | 5 (2–8) | 5 (3–7) | 5 (2–8) | 7 (5–9) | 8 (5–11) | 7 (4–10) |
| Zinc | 3 (2–4) | 3 (2–4) | 2 (1–3) | 2 (0–4) | 3 (1–5) | 2 (0–4) | 3 (1–5) | 3 (1–5) | 1 (0–2) | 4 (1–7) | 3 (1–5) | 2 (0–4) | 4 (1–7) h |
| Creatine | 1 (0–2) | 1 (0–2) | 1 (0–2) | 1 (−1–3) | 2 (1–3) f | 1 (0–2) f | 0 | 1 (1–3) | 0 | 0 | 1 (0–2) | 0 | 4 (1–7) h,j |
| B-alanine | 1 (0–2) | 1 (0–2) | 1 (0–2) | 1 (−1–3) | 1 (0–2) | 0 | 1 (0–2) | 1 (0–2) | 0 | 1 (0–2) | 1 (0–2) | 0 | 2 (0–4) h |
| Beetroot juice/nitrate | 1 (0–2) | 1 (0–2) | 1 (0–2) | 0 | 0 | 2 (1–3) | 1 (0–2) | 2 (0–4) | 0 | 1 (0–2) | 1 (0–2) | 2 (0–4) | 2 (0–4) |
| Sodium bicarbonate | 1 (0–2) | 1 (0–2) | 1 (0–2) | 1 (−1–3) | 0 | 1 (0–2) | 1 (0–2) | 1 (0–2) | 1 (0–2) | 1 (0–2) | 0 | 1 (0–2) | 1 (0–2) |
| HMB * | 0 | 1 (0–2) | 0 | 2 (0–4) | 0 | 1 (0–2) | 0 | 0 | 0 | 1 (0–2) | 1 (0–2) | 0 | 1 (0–2) |
| Quercetin | 0 | 0 | 0 | 0 | 0 | 1 (0–2) | 0 | 0 | 0 | 1 (0–2) | 0 | 0 | 0 |
| Other than these DS’s | 4 (3–5) | 3 (2–4) | 5 (3–7) a | 5 (0–10) | 6 (3–9) e,f | 3 (1–5) | 3 (1–5) | 3 (1–5) | 3 (1–5) | 5 (2–8) | 3 (2–4) | 5 (2–8) | 7 (4–10) h,j |
| None | 51 (50–52) | 57 (56–58) | 44 (42–46) | 55 (41–59) | 43 (40–46) | 53 (51–55) | 52 (50–54) | 54 (52–56) | 59 (57–61) | 49 (46–52) | 50 (49–51) | 47 (44–50) | 44 (41–47) |
| Energy drinks | 22 (20–24) | 27 (24–30) a | 16 (13–19) | 43 (34–52) e,f,g | 36 (31–41) e,f,g | 21 (17–25) f,g | 13 (10–16) g | 2 (0–4) | 10 (7–13) | 21 (14–28) h | 25 (21–29) h | 26 (5) h | 29 (6) h |
| Isotonic drinks | 19 (17–21) | 23 (20–26) a | 15 (12–18) | 37 (28–46) d,e,f,g | 27 (22–32) e,f,g | 21 (17–25) f,g | 11 (8–14) g | 5 (2–8) | 5 (3–7) | 17 (11–23) h | 20 (16–24) h | 28 (5) h,i,j | 30 (6) h,i,j |
| Protein shakes | 5 (4–6) | 5 (3–7) | 5 (3–8) | 7 (2–12) f,g | 10 (7–13) e,f,g | 6 (4–8) f,g | 3 (2–4) | 2 (0–4) | 2(1–3) | 3 (0–6) | 5 (3–7) h | 7 (3) h | 14 (4) h,i,j,k |
| Recovery drinks | 3 (2–4) | 5 (3–7) a | 1 (0–2) | 7 (2–12) f | 5 (3–7) f | 3 (1–5) | 1 (−1–3) | 0 | 0 | 1 (-1–3) | 3 (1–5) | 4 (2) | 8 (3) i,j,k |
| Energy gels | 1 (0–2) | 1 (0–2) | 1 (0–2) | 1 (−1–3) | 1 (0–2) | 2 (1–3) f | 0 | 0 | 0 | 1 (0–2) | 0 | 1 (1) | 4 (2) j,k |
| None of these SNPs | 66 (64–68) | 61 (58–64) | 72 (69–75) | 38 (37–39) | 49 (48–50) | 64 (63–65) | 80 (76–84) | 92 (88–96) | 86 (85–87) | 67 (66–68) | 64 (60–68) | 55 (54–56) | 52 (51–53) |
Sample size n = 1544, and sample size per subgroup was given as (n). All data is presented as a percentage and 95 CI. Capital letters are used as a label for subgroups within categories for gender, age, and sporting frequency. Lower case letters displayed below a specific value indicate that this value is significantly larger than the corresponding capital letters. * HMB: beta-hydroxy-beta-methylbutyrate.
Combined prevalence of use or non-use of dietary supplements and sports nutrition products or both for different groups.
| Age (Years) | Sporting Frequency per Year | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | 15–20 | 21–35 | 36–50 | 51–65 | 66–80 | 0 | 1–11 | 12–59 | 60–119 | >120 | |
| ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ||
| C | D | E | F | G | H | I | J | K | L | ||
| DS’s | 28 (26–30) | 10 (4–16) | 22 (18–26) c | 23 (19–27) c | 38 (34–42) c,d,e | 40 (34–46) c,d,e | 35 (30–40) j,k,l | 27 (19–35) | 27 (24–31) | 24 (19–29) | 25 (20–30) |
| SNPs | 12 (10–14) | 27 (19–35) d,e,f,g | 16 (12–20) f,g | 13 (10–16) g | 9 (6–12) g | 2 (0–4) | 8 (5–11) | 9 (4–14) | 12 (9–15) h | 16 (12–18) h,i | 17 (12–22) h,i |
| Both | 21 (19–23) | 35 (26–44) e,f,g | 35 (30–40) e,f,g | 24 (20–28) f,g | 11 (7–15) g | 6 (3–9) | 7 (5–9) | 24 (17–31) h | 24 (20–28) h | 29 (24–33) h | 31 (25–37) h,j |
| None | 38 (36–40) | 28 (20–36) | 27 (22–32) | 41 (36–47) c,d | 43 (38–48) c,d | 52 (46–58) c,d,e,f | 51 (46–56) i,j,k,l | 40 (32–48) | 37 (33–41) | 31 (25–36) | 27 (21–33) |
Sample size n = 1544, and sample size per subgroup was given as (n). All data is presented as a percentage and 95 CI. DS = dietary supplement; SNP = sports nutrition product. Capital letters are used as a label for subgroups within categories for gender, age, and sporting frequency. Lower case letters displayed below a specific value indicate that this value is significantly larger than the corresponding capital letters.
Percentage of health or performance reasons for the use of dietary supplements and sports nutrition products.
| Gender | Age (Years) | Sporting Frequency per Year | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Men | Women | 15–20 | 21–35 | 36–50 | 51–65 | 66–80 | 0 | 1–11 | 12–59 | 60–119 | >120 | |
| ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ||
| A | B | C | D | E | F | G | H | I | J | K | L | ||
| Health | 79 (77–81) | 72 (69–75) | 84 (80–88) a | 61 (53–69) | 74 (69–79) | 81 (76–86) c | 85 (80–90) c,d | 85 (79–91) c,d | 89 (84–94) i,j,k,l | 79 (71–87) i | 79 (75–83) i | 80 (74–86) i | 66 (60–72) |
| Performance | 3 (2–4) | 5 (4–6) b | 1 (0–2) | 4 (1–7) | 4 (2–6) f | 4 (3–5) f | 1 (0–2) | 1 (0–2) | 0 | 8 (5–11) | 3 (2–4) | 2 (1–3) | 3 (1–5) |
| Both | 11 (10–12) | 17 (15–19) b | 7 (6–8) | 25 (19–31) d,c,f,g | 12 (9–15) | 9 (7–11) | 9 (7–11) | 9 (7–11) | 1 (0–2) | 7 (4–10) h | 11 (9–13) h | 14 (11–17) h | 22 (18–26) h,i,j |
| Other | 7 (6–8) | 6 (5–7) | 9 (7–11) | 10 (6–14) | 11 (9–13) | 6 (4–8) | 6 (4–8) | 5 (3–7) | 10 (8–12) k | 6 (3–9) | 8 (6–10) | 4 (2–6) | 9 (6–12) |
| Health | 29 (27–31) | 25 (23–27) | 33 (31–35) | 17 (11–23) | 25 (22–28) | 32 (29–35) c | 40 (37–43) c,d | 43 (41–45) c | 31 (29–33) i | 35 (30–40) i | 29 (26–32) i | 33 (29–37) i | 18 (14–22) |
| Performance | 12 (11–13) | 15 (13–17) b | 7 (6–8) | 8 (4–12) | 16 (13–19) f | 12 (10–14) f | 4 (3–5) | 5 (4–6) | 0 | 9 (6–12) | 10 (8–12) | 10 (7–13) | 23 (19–27) i,j,k |
| Both | 23 (22–24) | 28 (26–30) b | 17 (15–29) | 28 (21–35) d | 17 (14–20) | 24 (21–27) | 29 (27–31) d | 29 (27–31) | 2 (1–3) | 11 (8–14) h | 26 (23–29) h,i | 23 (19–27) h | 34 (29–39) h,i |
| Other | 37 (35–39) | 32 (30–34) | 43 (41–45) a | 46 (38–54) e,f | 41 (37–44) f | 32 (29–35) | 27 (25–29) | 24 (22–26) | 67 (64–70) | 45 (39–51) | 34 (31–37) | 33 (29–37) | 25 (21–29) |
Sample size n = 1544, and sample size per subgroup was given as (n). All data is presented as a percentage and 95 CI. Capital letters are used as a label for subgroups within categories for gender, age and sporting frequency. Lower case letters displayed below a specific value indicate that this value is significantly larger than the corresponding capital letters.